The invention describes novel lercanidipine crude Forms (A) and (B), novel lercanidipine hydrochloride crystalline Forms (I) and (II) obtained form said crude Forms, pharmaceutical, antihypertensive compositions containing as active agent at least one of the lercanidipine hydrochloride crystalline Forms (I) and (II) and methods of use thereof.Sirovi čvrsti oblik (A) lerkanidipin hidrohlorida, naznačen time, što ima temperaturu topljenja oko 150-152°C (pik DSK) i sadrži oko 3-4 mas% etilacetata.Prijava sadrži još 55 patentnih zahteva.